$94.50
-1.24 (-1.30%)
At Close: Jun 03, 2026
Here's Why Crown Holdings (CCK) is a Strong Value Stock
10:40am, Monday, 23'rd Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Crown Completes Construction of First-of-Its-Kind Slant Well in Mexico
09:43am, Monday, 23'rd Dec 2024
LOS ANGELES, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ: CRKN) ("Crown" or the "Company”), a leading provider of innovative technology infrastructure solutions that benefi
Crown's Element 82 Secures Two New Lead Pipe Inspection Projects in New York
09:15am, Tuesday, 17'th Dec 2024
LOS ANGELES, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ: CRKN) ("Crown" or the "Company”), a leading provider of innovative technology infrastructure solutions that benefi
Crown Castle Stock: A Golden Opportunity Near 52-Week Lows For Long-Term Investors
07:32pm, Sunday, 15'th Dec 2024
Crown Castle (CCI) stock is trading near 52-week lows, presenting an attractive entry point for long-term investors with a robust 6.45% dividend yield. CCI's strategic focus on small cells and 5G infr
Is the Options Market Predicting a Spike in Crown Holdings (CCK) Stock?
09:35am, Thursday, 12'th Dec 2024
Investors need to pay close attention to Crown Holdings (CCK) stock based on the movements in the options market lately.
Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share
08:00am, Thursday, 12'th Dec 2024
Board of Directors of Revance Recommend Stockholders Tender their Shares JOHNSON CITY, Tenn. , Dec. 12, 2024 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown"), a privately held, global innovative lea
Is Crown Holdings (CCK) a Great Value Stock Right Now?
10:46am, Wednesday, 11'th Dec 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Revance agrees to lower-priced buyout offer by Crown Laboratories
09:12am, Monday, 09'th Dec 2024
Anti-wrinkle injection maker Revance Therapeutics has agreed to be bought for $3.10 per share by privately held Crown Laboratories, instead of $6.66 per share agreed previously, the two companies said
Crown Announces Plans to Build and Co-Own Reverse Osmosis Plant in Mexico to Desalinate Water Collected from Slant Wells
09:00am, Monday, 09'th Dec 2024
In Partnership With Mexico's 529 Capital, A Leading Real Estate Development Firm From The Baja Peninsula Expected To Produce Up To An Estimated $40 Million In Recurring Annual Revenue LOS ANGELES, Dec
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
08:30am, Monday, 09'th Dec 2024
JOHNSON CITY, Tenn. and NASHVILLE, Tenn.
Crown Expands Fiber Optics Services Footprint With Leading Regional Internet Provider in Oregon
09:30am, Wednesday, 04'th Dec 2024
LOS ANGELES, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading provider of innovative technology infrastructure solutions that
CROWN HOLDINGS, INC. TO RECEIVE PROCEEDS FROM CLOSING OF EVIOSYS SALE TO SONOCO PRODUCTS COMPANY
09:06am, Wednesday, 04'th Dec 2024
TAMPA, Fla. , Dec. 4, 2024 /PRNewswire/ -- Following the closing today of the previously announced sale of Eviosys to Sonoco Products Company, Crown Holdings, Inc. (NYSE: CCK) (Crown) will rec
Why Crown Holdings (CCK) is a Top Value Stock for the Long-Term
10:45am, Tuesday, 03'rd Dec 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Crown Castle: Analyzing Historical And Future Fair Value
10:00am, Sunday, 01'st Dec 2024
Crown Castle Inc (CCI) is trading at 15% above its 52-week low, offering a 39% upside based on historical fair value metrics. Using a dividend discount model, CCI's fair value is estimated at $146, im
VENU's Crown Jewel, Ford Amphitheater, Nominated for Pollstar Magazine's Coveted 2024 New Concert Venue of the Year Award
09:30am, Thursday, 21'st Nov 2024
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation (VENU), premium live entertainment and hospitality company and owner of Ford Amphitheater in Colorado Springs, has been nominated for
Sign In
Buy CCK